This dissertation discusses the design approaches of adaptive dose escalation study and the analysis methods of dose study data, and the relationship between the study design approach and data analysis methods.A general max-min approach to construct simultaneous confidence Intervals for the monotone means of correlated and normally istributed random samples is proposed to analyze correlated dose response data. The approach provides an accurate, flexible and computationally easy way to obtain critical values of simultaneous confidence intervals under monotone order restriction.Stepdown testing procedure for analyzing dose study data is examined and an modified stepdown testing approach is proposed to incorporate the adaptive sampling nature ...
In a dose-escalation trial for a new drug, each successive dose is tested on a new cohort of volunte...
grantor: University of TorontoMethods of statistical inference are developed which can be ...
Early phase, or phase I and phase II, trials are the first step in testing new medicines that have b...
This dissertation discusses the design approaches of adaptive dose escalation study and the analysis...
This dissertation discusses the design approaches of adaptive dose escalation study and the analysis...
As most adaptive clinical trial designs are implemented in stages, well-understood methods of sequen...
One of the common applications of simultaneous inference problems is in the dose-response study, whe...
Dose-response experiments and subsequent data analyses are often carried out according to optimal de...
We consider the problem of how to efficiently and safely design dose finding studies. Both current a...
Dose escalation trials for identifying the maximum tolerable dose (MTD) is commonly considered in ph...
In clinical drug development, searching for the true dose-response curve is ethically and logistical...
In clinical drug development, searching for the true dose-response curve is ethically and logistical...
This research examines new design approaches for Phase I clinical trials, which are designed to stud...
This research examines new design approaches for Phase I clinical trials, which are designed to stud...
Designs are explored that minimize the asymptotic variance of a single parameter in a dose-response ...
In a dose-escalation trial for a new drug, each successive dose is tested on a new cohort of volunte...
grantor: University of TorontoMethods of statistical inference are developed which can be ...
Early phase, or phase I and phase II, trials are the first step in testing new medicines that have b...
This dissertation discusses the design approaches of adaptive dose escalation study and the analysis...
This dissertation discusses the design approaches of adaptive dose escalation study and the analysis...
As most adaptive clinical trial designs are implemented in stages, well-understood methods of sequen...
One of the common applications of simultaneous inference problems is in the dose-response study, whe...
Dose-response experiments and subsequent data analyses are often carried out according to optimal de...
We consider the problem of how to efficiently and safely design dose finding studies. Both current a...
Dose escalation trials for identifying the maximum tolerable dose (MTD) is commonly considered in ph...
In clinical drug development, searching for the true dose-response curve is ethically and logistical...
In clinical drug development, searching for the true dose-response curve is ethically and logistical...
This research examines new design approaches for Phase I clinical trials, which are designed to stud...
This research examines new design approaches for Phase I clinical trials, which are designed to stud...
Designs are explored that minimize the asymptotic variance of a single parameter in a dose-response ...
In a dose-escalation trial for a new drug, each successive dose is tested on a new cohort of volunte...
grantor: University of TorontoMethods of statistical inference are developed which can be ...
Early phase, or phase I and phase II, trials are the first step in testing new medicines that have b...